Previvor Edge Expands Platform to Deliver Personalized Cancer Risk Profiles and Prevention Plans

The AI-driven platform generates clinical-grade risk assessments and interactive digital care plans in a single visit.

Mar. 24, 2026 at 10:37am

Got story updates? Submit your updates here. ›

Previvor Edge, a preventive cancer care organization, has announced an expansion of its clinical platform that dramatically accelerates the delivery of personalized cancer prevention guidance. The expanded platform enables Previvor Edge clinicians to rapidly translate complex genetic, medical, family history, and lifestyle risk data into a comprehensive Cancer Risk Profile and personalized prevention and early detection strategy during a single clinical visit.

Why it matters

Historically, cancer risk information has been fragmented and difficult to translate into practical next steps for patients. Previvor Edge's expanded platform addresses this challenge by enabling clinicians to rapidly generate a structured Cancer Risk Profile, a personalized prevention and early detection action plan, and an interactive digital care plan with clear next steps for patients.

The details

The expansion allows Previvor Edge clinicians to synthesize complex risk factors more efficiently and deliver structured, actionable guidance. Patients complete a brief online assessment before their appointment, which the clinician reviews alongside other relevant risk factors. During the visit, the clinician evaluates the patient's full risk profile, orders genetic and other testing as appropriate, and adjusts recommendations as needed. Immediately afterward, patients receive an interactive digital care plan outlining their risk inputs, Cancer Risk Profile, and practical next steps, along with a report they can share with their other healthcare providers.

  • Previvor Edge launched its clinical program and has been evaluating patients across a wide range of cancer risk profiles.
  • The expanded platform was announced on March 24, 2026.

The players

Previvor Edge

A preventive cancer care organization that has expanded its clinical platform to deliver personalized cancer prevention guidance.

Michelle Zimmerman

The co-founder and CEO of Previvor Edge, who previously built the oncology business at genomics leader Sema4 (now GeneDx).

Sven Karlsson

The co-founder of Previvor Edge, an experienced healthcare operator focused on building and scaling healthcare companies.

Got photos? Submit your photos here. ›

What they’re saying

“This expansion allows us to deliver deeper insights to patients while maintaining the clinical expertise that is essential in cancer prevention.”

— Michelle Zimmerman, Co-Founder and CEO of Previvor Edge

What’s next

The expanded platform scales Previvor Edge's multidisciplinary prevention model while preserving a consistent, guideline-driven foundation that integrates advanced technologies like liquid biopsies, new algorithms, and imaging to personalize cancer prevention.

The takeaway

Previvor Edge's expanded platform addresses the historical challenge of fragmented cancer risk information by enabling clinicians to rapidly generate a comprehensive Cancer Risk Profile and personalized prevention and early detection plan, empowering patients to take proactive steps to reduce their cancer risk.